An investigation into the metabolic and cardiovascular effects of phytocannabinoids using in vivo and in vitro techniques
Metabolic syndrome, first described as Syndrome X, includes a cluster of metabolic abnormalities including visceral obesity, insulin resistance, dyslipidaemia and hypertension. The pathophysiology of metabolic syndrome is complex, however, visceral adiposity and insulin resistance are thought to pla...
Main Author: | |
---|---|
Published: |
University of Nottingham
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701229 |